Key result
Symptom-guided therapy directs diastolic heart failure care while typical systolic medications risk causing harm.
Why the study?
Pharmaceutical therapy used for systolic dysfunction may be harmful in diastolic heart failure, highlighting the need to understand appropriate symptom-mediated therapy.
The primary therapeutic goal in treating diastolic heart failure is symptom-mediated therapy, and therapies for systolic dysfunction may be harmful.
Answers are grounded in this paper and cite their sources.
Favors symptom-directed care in diastolic HF; challenges HFrEF drug use and leaves optimal therapy open to trials.
The primary therapeutic goal in treating diastolic heart failure is to restore physiologic balance using symptom-mediated therapy. Pharmaceutical therapy used for systolic dysfunction may actually be harmful.
No takes yet. Share an insight, caveat, or question.
Vishali Chand (2006) studied this question. Symptom-mediated therapy is the primary treatment goal for diastolic heart failure, whereas pharmaceutical therapies typically used for systolic dysfunction may actually be harmful.
Synapse has enriched 10 related papers. Consider them for comparative context: